El Punt Avui, La Razón, El Periódico, El Economista, among other media, have published an article about the research that was financed with the 12 million euros collected in TV3’s 2012 Marató (telethon) dedicated to cancer. La Marató has highlighted, among others, two IRB Barcelona projects that were awarded funding. On the one hand, Núria López-Bigas developed the "Cancer Genome Interpreter", a platform that allows better selection of treatments for cancer and the prediction of patient response. And on the other, Salvador Aznar Benitah led a project addressing metastasis and its relation to the consumption of dietary fat.
Link to El Periódico
Link to El Economista
TV3’s programme “Els Matins” has interviewed Francesc Posas, director of IRB Barcelona, about the increase in donations given to NGOs and research centres in Catalonia and about the #Metastasis Challenge campaign. During the interview, he talked about the importance of small fundraising initiatives undertaken by individuals, such as that of Magdalena Socias, a cancer patient who has decided to join the challenge by walking the Sierra de Tramontana to give visibility to the fight against metastasis.
Many treatments against cancer, such as TRAIL, aim to trigger a type of cell death known as apoptosis.
A team at IRB Barcelona, headed by Antonio Zorzano, has demonstrated that the protein TP53INP2 induces apoptosis in chemotherapy treatments.
The radio station Cope, and the newspapers Ara Balear, Diario de Mallorca and Ultima Hora, among other media, have echoed news about the personal challenge taken on by Magdalena Socias, a cancer patient in Majorca, who intends to cross La Serra de Tramuntana on foot in order to increase awareness of the fight against the metastasis. This hike is part of the #MetastasisChallenge campaign, through which the Institute for Research in Biomedicine (IRB Barcelona) aims to raise €5 M over the next four years to boost research in this field.
